Neuroinflammation, a major contributor to neurodegenerative diseases, involves the contribution of activated microglia, reactive astrocytes, and infiltrating inflammatory cells. Stress and various acute or chronic brain injuries stimulate the generation of free radicals and glutamate, triggering inflammatory pathways that lead to increases in chemokines, cytokines, and prostaglandins. Prostaglandins are lipid mediators of inflammation that are produced from arachidonic acid by cyclooxygenase enzymes. They are generally believed to be in all tissues and organs. Their transport through the lipid bilayers of the cell membranes/organelles is facilitated by the prostaglandin transporter (PGT). In this study, middle frontal gyrus brain tissue from patients diagnosed with Alzheimer disease (AD) and that of age-matched control brains were examined to determine the protein expression pattern of PGT and its possible role in modulating neuroinflammation associated with AD. Immunohistochemical and immunofluorescent studies showed that PGT protein was expressed in all the brain tissues examined and was localized in neurons, microglia, and astrocytes. Interestingly, Western blot analysis revealed that the PGT level was significantly less in AD than in age-matched control brain homogenates. Further work is warranted to address the possibility and implications that prostaglandins might not be cleared at a proper rate in AD brains.
Introduction
Alzheimer disease (AD), one of the most prominent neurodegenerative diseases, is characterized by progressive mental decline, including memory loss, behavioral abnormalities, and language impairment. The neuritic plaques and neurofibrillary tangles associated with AD, strongly imply a link with neuroinflammation (Halliday et al., 2000; McGeer and McGeer, 2003; Tuppo and Arias, 2005) . When an area of the brain is injured, a high level of glutamate is generated that initiates the inflammatory pathway by activating microglia, astrocytes, and infiltrating leukocytes (Engelhardt et al., 1989 (Engelhardt et al., , 1993 Kawamata et al., 1992; Lampson et al., 1990; Schiffer et al., 1996; Troost et al., 1990) . The inflammatory mediators produced include cytokines, cyclooxygenase (COX) 1 and 2, and prostaglandins. Thus, it has been reported that COX activity and prostaglandin levels are higher in the brains of AD patients than in control brains (Consilvio et al., 2004; Donnelly and Hawkey, 1997; Montine et al., 1999a,b; Pasinetti, 1998) .
Prostaglandins are carried across the cell membrane by the prostaglandin transporter (PGT). PGT has been identified and shown to have a role in the release of newly synthesized prostaglandins from cells, the transepithelial transport of prostaglandins, and the clearance of prostaglandins from the circulation for the termination of signaling (Kanai et al., 1995) . PGT protein is expressed by prostanoid-releasing cells (Bao et al., 2002) , and Northern blot analysis has shown that PGT mRNA is expressed in amygdala, caudate nucleus, corpus callosum, hippocampus,
